From: Hypercholesterolemia and Myocardial function evaluated via Tissue Doppler Imaging
Literature (17) | Control (group 1) | With Ezetemibe (group 2) | Without Ezetemibe (group 3) | |
---|---|---|---|---|
Weight (kg) | 2.59 | 3.1 ± 0.26 | 3.11 ± 0.16 | 3.05 ± 0.2 |
E/A * | 2.19 | 1.80 ± 0.51 | 1.92 ± 0.37 | 1.55 ± 0.49 |
E'/A'‡ | NA | 1.93 ± 0.42 | 1.82 ± 0.22 | 1.26 ± 0.62 |
S'‡ | NA | 6.42 ± 2.55 | 6.55 ± 1.66 | 4.6 ± 0.69 |
E/E' | NA | 8.91 ± 1.54 | 8.48 ± 2.15 | 11.72 ± 5.33 |
E wave (cm/s) | 59 | 60.6 ± 9.9 | 59.1 ± 8.5 | 58.0 ± 9.2 |
E dec (sec) | NA | 87.8 ± 22.5 | 93.4 ± 18.5 | 102.1 ± 22.1 |
IVSd (mm) | 2.03 | 2.85 ± 0.37 | 2.87 ± 0.35 | 3.11 ± 0.60 |
IVSs (mm) | 3.05 | 4.14 ± 0.69 | 4.25 ± 0.70 | 3.88 ± 0.33 |
LVIDd (mm) | 14.37 | 15.14 ± 0.69 | 14.62 ± 2.38 | 14.77 ± 2.16 |
LVIDs (mm) | 10.05 | 10.14 ± 0.37 | 10.5 ± 2.07 | 10.77 ± 1.85 |
LVFWd (mm) | 2.16 | 3 ± 0.0 | 2.5 ± 0.75 | 2.66 ± 0.5 |
LVFWs (mm) | 3.48 | 4.14 ± 0.89 | 3.62 ± 0.51 | 3.77 ± 0.66 |
FS (%) | 30.13 | 30.85 ± 3.5 | 28.37 ± 6.36 | 28.22 ± 4.76 |
EF (%) | 61.29 | 62.28 ± 5.02 | 58.37 ± 9.7 | 58.44 ± 7.76 |
Ao (mm) | 8.26 | 9.42 ± 0.78 | 9.25 ± 1.48 | 9.33 ± 0.86 |
LA (mm) | 9.66 | 8.85 ± 1.06 | 8.5 ± 1.41 | 9.33 ± 2.64 |